Petosemtamab: Clinical Trials

1 trial of Petosemtamab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Petosemtamab: new trials by email Literature Review of Petosemtamab trials Research Report on Petosemtamab

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
MCLA-158, MCLA-158 + Pembrolizumab, MCLA-158 + FOLFIRI - Advanced/Metastatic Solid Tumors, Colorectal Cancer
Phase 1 / Phase 2RecruitingGenmab5602018-05-022026-11-02

Conditions studied

Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Sponsors

Genmab (1)

Countries

Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2017 (1)